abstract |
(57) [Summary] [PROBLEMS] To provide a pharmaceutical composition having an extremely strong inhibitory effect on hyperactivity of respiratory glands such as runny nose. A pharmaceutical composition comprising (a) an anticholinergic and (b) at least one drug selected from the group consisting of ketotifen, epinastine and salts thereof. |